Advertisement
Andrology| Volume 20, SUPPLEMENT 2, S35, October 2020

Impact of extracorporeal shock wave therapy for erectile dysfunction and Peyronie’s disease on hormonal and reproductive testicular function: Results from a randomized controlled trial

Open AccessDOI:https://doi.org/10.1016/S2666-1683(20)35331-3
Impact of extracorporeal shock wave therapy for erectile dysfunction and Peyronie’s disease on hormonal and reproductive testicular function: Results from a randomized controlled trial
Previous ArticleDiagnosis of Peyronie’s disease and Shear Wave Elastosonography of the penis: New non-invasive method
Next ArticlemiR-20a-5p expression as a potential non-invasive diagnostic biomarker in patients with non-obstructive azoospermia
      This paper is only available as a PDF. To read, Please Download here.

      Article info

      Identification

      DOI: https://doi.org/10.1016/S2666-1683(20)35331-3

      Copyright

      © 2020 European Association of Urology. Published by Elsevier Inc.

      User license

      Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
      How you can reuse Information Icon
      Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Redistribute or republish the final article
      • Text & data mine
      • Translate the article (private use only, not for distribution)
      • Reuse portions or extracts from the article in other works

      Not Permitted

      • Sell or re-use for commercial purposes
      • Distribute translations or adaptations of the article

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX